Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

BACKGROUND: Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction. METHODS: To assess the incidence and the spectrum of endocrinopathies in melanoma patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassi, Eva, Angelousi, Anna, Asonitis, Nikolaos, Diamantopoulos, Panagiotis, Anastasopoulou, Amalia, Papaxoinis, George, Kokkinos, Michalis, Giovanopoulos, Ilias, Kyriakakis, Georgios, Petychaki, Fotini, Savelli, Akrivi, Benopoulou, Olga, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825974/
https://www.ncbi.nlm.nih.gov/pubmed/31518074
http://dx.doi.org/10.1002/cam4.2533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825974/
https://www.ncbi.nlm.nih.gov/pubmed/31518074
http://dx.doi.org/10.1002/cam4.2533

Ejemplares similares